Literature DB >> 12470322

Sex differences in cobalamin vitamin B12 opinions of Swedish physicians.

Mats Nilsson1, Johan Lökk, Bo Norberg, Johan Hultdin, Herbert Sandström, Göran Westman.   

Abstract

The aim of the study was to elucidate possible sex differences in knowledge, competence and attitudes behind decision-making on cobalamin-associated problems (vitamin B(12)). The study was conducted by postal questionnaires to Swedish physicians in 1996-98. The participants were recruited by random sampling of general practitioners (1996, 1998), and a total sampling of geriatricians (1998). The overall response rate was 71%. The study group comprised 480 female physicians and 526 male physicians. The responses to 24 statements in the questionnaire were measured by means of visual analogue scales. Group differences were evaluated by medians and shapes of distributions. The female doctors appeared to value patient-related symptoms and signs more than male doctors. Conversely, male doctors relied on laboratory tests more than female doctors. As reflected by questionnaire answers, female doctors appeared to be more informed than male doctors on cobalamin-associated clinical problems. Group differences between the sexes were marginal from a numerical point of view. It is suggested that the statistical differences observed should be regarded as negligible until confirmed by further studies.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12470322     DOI: 10.1080/08039480260242804

Source DB:  PubMed          Journal:  Nord J Psychiatry        ISSN: 0803-9488            Impact factor:   2.202


  2 in total

1.  Medical intelligence in Sweden. Vitamin B12: oral compared with parenteral?

Authors:  M Nilsson; B Norberg; J Hultdin; H Sandström; G Westman; J Lökk
Journal:  Postgrad Med J       Date:  2005-03       Impact factor: 2.401

2.  Oral vitamin B12 therapy in the primary care setting: a qualitative and quantitative study of patient perspectives.

Authors:  Jeff C Kwong; David Carr; Irfan A Dhalla; Denise Tom-Kun; Ross E G Upshur
Journal:  BMC Fam Pract       Date:  2005-02-21       Impact factor: 2.497

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.